|
1
|
Rapid diagnostic tests for malaria at sites of varying transmission intensity in Uganda.
|
J Infect Dis
|
2008
|
4.60
|
|
2
|
In vivo parasitological measures of artemisinin susceptibility.
|
J Infect Dis
|
2010
|
4.25
|
|
3
|
Treatment of malaria restricted to laboratory-confirmed cases: a prospective cohort study in Ugandan children.
|
Malar J
|
2007
|
4.05
|
|
4
|
Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp.
|
Am J Trop Med Hyg
|
2003
|
3.71
|
|
5
|
Home management of malaria with artemether-lumefantrine compared with standard care in urban Ugandan children: a randomised controlled trial.
|
Lancet
|
2009
|
3.21
|
|
6
|
Combination treatments for uncomplicated falciparum malaria in Kampala, Uganda: randomised clinical trial.
|
Lancet
|
2004
|
3.12
|
|
7
|
Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial.
|
Lancet
|
2007
|
2.99
|
|
8
|
Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial.
|
BMJ
|
2009
|
2.84
|
|
9
|
Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda.
|
PLoS One
|
2008
|
2.78
|
|
10
|
Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic.
|
Antimicrob Agents Chemother
|
2006
|
2.74
|
|
11
|
Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda.
|
PLoS Clin Trials
|
2006
|
2.72
|
|
12
|
Short report: proximity to mosquito breeding sites as a risk factor for clinical malaria episodes in an urban cohort of Ugandan children.
|
Am J Trop Med Hyg
|
2003
|
2.68
|
|
13
|
Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial.
|
PLoS Clin Trials
|
2007
|
2.63
|
|
14
|
Effect of HIV-1 infection on antimalarial treatment outcomes in Uganda: a population-based study.
|
J Infect Dis
|
2005
|
2.51
|
|
15
|
Malaria in Uganda: challenges to control on the long road to elimination: I. Epidemiology and current control efforts.
|
Acta Trop
|
2011
|
2.46
|
|
16
|
Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
|
Clin Infect Dis
|
2007
|
2.44
|
|
17
|
Validation of microsatellite markers for use in genotyping polyclonal Plasmodium falciparum infections.
|
Am J Trop Med Hyg
|
2006
|
2.43
|
|
18
|
Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children.
|
Clin Infect Dis
|
2009
|
2.42
|
|
19
|
Improved malaria case management after integrated team-based training of health care workers in Uganda.
|
Am J Trop Med Hyg
|
2008
|
2.42
|
|
20
|
Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda.
|
PLoS Med
|
2005
|
2.33
|
|
21
|
Comparison of HRP2- and pLDH-based rapid diagnostic tests for malaria with longitudinal follow-up in Kampala, Uganda.
|
Am J Trop Med Hyg
|
2007
|
2.30
|
|
22
|
Factors determining the heterogeneity of malaria incidence in children in Kampala, Uganda.
|
J Infect Dis
|
2008
|
2.28
|
|
23
|
Likely health outcomes for untreated acute febrile illness in the tropics in decision and economic models; a Delphi survey.
|
PLoS One
|
2011
|
2.24
|
|
24
|
Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis.
|
PLoS One
|
2009
|
2.05
|
|
25
|
High risk of neutropenia in HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda.
|
Clin Infect Dis
|
2008
|
2.05
|
|
26
|
Antibodies to Plasmodium falciparum antigens predict a higher risk of malaria but protection from symptoms once parasitemic.
|
J Infect Dis
|
2011
|
1.98
|
|
27
|
Neurocognitive and motor deficits in HIV-infected Ugandan children with high CD4 cell counts.
|
Clin Infect Dis
|
2012
|
1.97
|
|
28
|
Comparative efficacy of aminoquinoline-antifolate combinations for the treatment of uncomplicated falciparum malaria in Kampala, Uganda.
|
Am J Trop Med Hyg
|
2003
|
1.96
|
|
29
|
Improved malaria case management through the implementation of a health facility-based sentinel site surveillance system in Uganda.
|
PLoS One
|
2011
|
1.94
|
|
30
|
Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance.
|
J Infect Dis
|
2006
|
1.93
|
|
31
|
Lopinavir/ritonavir affects pharmacokinetic exposure of artemether/lumefantrine in HIV-uninfected healthy volunteers.
|
J Acquir Immune Defic Syndr
|
2009
|
1.83
|
|
32
|
Surveillance for malaria elimination in Swaziland: a national cross-sectional study using pooled PCR and serology.
|
PLoS One
|
2012
|
1.81
|
|
33
|
Longitudinal study of urban malaria in a cohort of Ugandan children: description of study site, census and recruitment.
|
Malar J
|
2006
|
1.81
|
|
34
|
Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis.
|
Malar J
|
2009
|
1.80
|
|
35
|
Effects of trimethoprim-sulfamethoxazole and insecticide-treated bednets on malaria among HIV-infected Ugandan children.
|
AIDS
|
2007
|
1.79
|
|
36
|
PCR-based pooling of dried blood spots for detection of malaria parasites: optimization and application to a cohort of Ugandan children.
|
J Clin Microbiol
|
2010
|
1.77
|
|
37
|
Impact of transmission intensity on the accuracy of genotyping to distinguish recrudescence from new infection in antimalarial clinical trials.
|
Antimicrob Agents Chemother
|
2007
|
1.75
|
|
38
|
Asymptomatic parasitaemia as a risk factor for symptomatic malaria in a cohort of Ugandan children.
|
Trop Med Int Health
|
2004
|
1.74
|
|
39
|
The use of genotyping in antimalarial clinical trials: a systematic review of published studies from 1995-2005.
|
Malar J
|
2006
|
1.73
|
|
40
|
Estimating the annual entomological inoculation rate for Plasmodium falciparum transmitted by Anopheles gambiae s.l. using three sampling methods in three sites in Uganda.
|
Malar J
|
2014
|
1.73
|
|
41
|
Increasing incidence of malaria in children despite insecticide-treated bed nets and prompt anti-malarial therapy in Tororo, Uganda.
|
Malar J
|
2012
|
1.65
|
|
42
|
Roles of specific Plasmodium falciparum mutations in resistance to amodiaquine and sulfadoxine-pyrimethamine in Burkina Faso.
|
Am J Trop Med Hyg
|
2006
|
1.64
|
|
43
|
Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: a randomised clinical trial.
|
BMJ
|
2011
|
1.62
|
|
44
|
Distinguishing recrudescences from new infections in antimalarial clinical trials: major impact of interpretation of genotyping results on estimates of drug efficacy.
|
Am J Trop Med Hyg
|
2005
|
1.59
|
|
45
|
Validation of a simplified method for using molecular markers to predict sulfadoxine-pyrimethamine treatment failure in African children with falciparum malaria.
|
Am J Trop Med Hyg
|
2003
|
1.59
|
|
46
|
Antiretroviral agents and prevention of malaria in HIV-infected Ugandan children.
|
N Engl J Med
|
2012
|
1.58
|
|
47
|
World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs.
|
Malar J
|
2007
|
1.56
|
|
48
|
Relationship between age, molecular markers, and response to sulphadoxine-pyrimethamine treatment in Kampala, Uganda.
|
Trop Med Int Health
|
2004
|
1.56
|
|
49
|
Sulfadoxine-pyrimethamine plus chloroquine or amodiaquine for uncomplicated falciparum malaria: a randomized, multisite trial to guide national policy in Uganda.
|
Am J Trop Med Hyg
|
2005
|
1.53
|
|
50
|
Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala, Uganda.
|
Antimicrob Agents Chemother
|
2009
|
1.52
|
|
51
|
Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.
|
Am J Trop Med Hyg
|
2014
|
1.51
|
|
52
|
Discordant patterns of genetic variation at two chloroquine resistance loci in worldwide populations of the malaria parasite Plasmodium falciparum.
|
Antimicrob Agents Chemother
|
2008
|
1.50
|
|
53
|
Indoor residual spraying of insecticide and malaria morbidity in a high transmission intensity area of Uganda.
|
PLoS One
|
2012
|
1.46
|
|
54
|
Evaluation of a comprehensive refresher training program in malaria microscopy covering four districts of Uganda.
|
Am J Trop Med Hyg
|
2011
|
1.45
|
|
55
|
Impact of intermittent preventive treatment with dihydroartemisinin-piperaquine on malaria in Ugandan schoolchildren: a randomized, placebo-controlled trial.
|
Clin Infect Dis
|
2014
|
1.44
|
|
56
|
Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in Uganda.
|
Antimicrob Agents Chemother
|
2007
|
1.44
|
|
57
|
Use of the slide positivity rate to estimate changes in malaria incidence in a cohort of Ugandan children.
|
Malar J
|
2009
|
1.43
|
|
58
|
Incidence of malaria and efficacy of combination antimalarial therapies over 4 years in an urban cohort of Ugandan children.
|
PLoS One
|
2010
|
1.42
|
|
59
|
Urban malaria: primary caregivers' knowledge, attitudes, practices and predictors of malaria incidence in a cohort of Ugandan children.
|
Trop Med Int Health
|
2003
|
1.40
|
|
60
|
The seroprevalence of Helicobacter pylori and its relationship to malaria in Ugandan children.
|
Trans R Soc Trop Med Hyg
|
2011
|
1.39
|
|
61
|
Effect of trimethoprim-sulphamethoxazole on the risk of malaria in HIV-infected Ugandan children living in an area of widespread antifolate resistance.
|
Malar J
|
2010
|
1.34
|
|
62
|
False-positive results of enzyme immunoassays for human immunodeficiency virus in patients with uncomplicated malaria.
|
J Clin Microbiol
|
2006
|
1.34
|
|
63
|
Acute HIV-1 infection is highly prevalent in Ugandan adults with suspected malaria.
|
AIDS
|
2010
|
1.32
|
|
64
|
Standardised versus actual white cell counts in estimating thick film parasitaemia in African children under five.
|
Trop Med Int Health
|
2011
|
1.32
|
|
65
|
Assessing the impact of indoor residual spraying on malaria morbidity using a sentinel site surveillance system in Western Uganda.
|
Am J Trop Med Hyg
|
2009
|
1.31
|
|
66
|
Amodiaquine, sulfadoxine-pyrimethamine, and combination therapy for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso.
|
Am J Trop Med Hyg
|
2005
|
1.29
|
|
67
|
The relationship between the haemoglobin concentration and the haematocrit in Plasmodium falciparum malaria.
|
Malar J
|
2008
|
1.29
|
|
68
|
Efficacy, safety, and tolerability of three regimens for prevention of malaria: a randomized, placebo-controlled trial in Ugandan schoolchildren.
|
PLoS One
|
2010
|
1.27
|
|
69
|
Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children.
|
Malar J
|
2008
|
1.27
|
|
70
|
Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria.
|
Malar J
|
2014
|
1.24
|
|
71
|
Evaluating tuberculosis case detection via real-time monitoring of tuberculosis diagnostic services.
|
Am J Respir Crit Care Med
|
2011
|
1.24
|
|
72
|
Kaposi sarcoma-associated herpesvirus (KSHV) seroprevalence in population-based samples of African children: evidence for at least 2 patterns of KSHV transmission.
|
J Infect Dis
|
2009
|
1.22
|
|
73
|
Improved clinical and laboratory skills after team-based, malaria case management training of health care professionals in Uganda.
|
Malar J
|
2012
|
1.20
|
|
74
|
Effect of cotrimoxazole prophylaxis taken by human immunodeficiency virus (HIV)-infected persons on the selection of sulfadoxine-pyrimethamine-resistant malaria parasites among HIV-uninfected household members.
|
Am J Trop Med Hyg
|
2006
|
1.20
|
|
75
|
Hepatotoxicity due to a drug interaction between amodiaquine plus artesunate and efavirenz.
|
Clin Infect Dis
|
2007
|
1.19
|
|
76
|
Host polymorphisms and the incidence of malaria in Ugandan children.
|
Am J Trop Med Hyg
|
2004
|
1.18
|
|
77
|
Hematologic parameters in pediatric uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa.
|
Am J Trop Med Hyg
|
2011
|
1.14
|
|
78
|
Decreasing efficacy of antimalarial combination therapy in Uganda is explained by decreasing host immunity rather than increasing drug resistance.
|
J Infect Dis
|
2009
|
1.14
|
|
79
|
Evidence for both innate and acquired mechanisms of protection from Plasmodium falciparum in children with sickle cell trait.
|
Blood
|
2012
|
1.13
|
|
80
|
Molecular evaluation of the natural history of asymptomatic parasitemia in Ugandan children.
|
J Infect Dis
|
2004
|
1.13
|
|
81
|
Prevention and treatment strategies used for the community management of childhood fever in Kampala, Uganda.
|
Am J Trop Med Hyg
|
2006
|
1.12
|
|
82
|
Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children.
|
Malar J
|
2009
|
1.12
|
|
83
|
Complexity of Plasmodium falciparum clinical samples from Uganda during short-term culture.
|
J Infect Dis
|
2008
|
1.12
|
|
84
|
Complexity of Plasmodium falciparum infections and antimalarial drug efficacy at 7 sites in Uganda.
|
J Infect Dis
|
2006
|
1.11
|
|
85
|
Placental malaria among HIV-infected and uninfected women receiving anti-folates in a high transmission area of Uganda.
|
Malar J
|
2009
|
1.11
|
|
86
|
Intermittent preventive therapy with sulfadoxine-pyrimethamine for malaria in pregnancy: a cross-sectional study from Tororo, Uganda.
|
PLoS One
|
2013
|
1.10
|
|
87
|
Malaria in Uganda: challenges to control on the long road to elimination. II. The path forward.
|
Acta Trop
|
2011
|
1.09
|
|
88
|
The association between malnutrition and the incidence of malaria among young HIV-infected and -uninfected Ugandan children: a prospective study.
|
Malar J
|
2012
|
1.05
|
|
89
|
Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine for uncomplicated malaria: a systematic review.
|
Trop Med Int Health
|
2006
|
1.05
|
|
90
|
The effect of indoor residual spraying on malaria and anemia in a high-transmission area of northern Uganda.
|
Am J Trop Med Hyg
|
2013
|
1.05
|
|
91
|
Early virologic failure and the development of antiretroviral drug resistance mutations in HIV-infected Ugandan children.
|
J Acquir Immune Defic Syndr
|
2011
|
1.04
|
|
92
|
Gel versus capillary electrophoresis genotyping for categorizing treatment outcomes in two anti-malarial trials in Uganda.
|
Malar J
|
2010
|
1.04
|
|
93
|
Monitoring antimalarial safety and tolerability in clinical trials: a case study from Uganda.
|
Malar J
|
2008
|
1.02
|
|
94
|
Anti-malarial prescription practices among outpatients with laboratory-confirmed malaria in the setting of a health facility-based sentinel site surveillance system in Uganda.
|
Malar J
|
2013
|
1.02
|
|
95
|
Clinical tolerability of artesunate-amodiaquine versus comparator treatments for uncomplicated falciparum malaria: an individual-patient analysis of eight randomized controlled trials in sub-Saharan Africa.
|
Malar J
|
2012
|
1.01
|
|
96
|
Factors associated with malaria parasitaemia, malnutrition, and anaemia among HIV-exposed and unexposed Ugandan infants: a cross-sectional survey.
|
Malar J
|
2012
|
1.00
|
|
97
|
Effect of nutritional status on response to treatment with artemisinin-based combination therapy in young Ugandan children with malaria.
|
Antimicrob Agents Chemother
|
2011
|
1.00
|
|
98
|
Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient data.
|
BMC Med
|
2015
|
0.99
|
|
99
|
Concomitant efavirenz reduces pharmacokinetic exposure to the antimalarial drug artemether-lumefantrine in healthy volunteers.
|
J Acquir Immune Defic Syndr
|
2012
|
0.99
|
|
100
|
The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data.
|
BMC Med
|
2015
|
0.99
|
|
101
|
Plasmodium falciparum clearance in clinical studies of artesunate-amodiaquine and comparator treatments in sub-Saharan Africa, 1999-2009.
|
Malar J
|
2014
|
0.98
|
|
102
|
The PRIME trial protocol: evaluating the impact of an intervention implemented in public health centres on management of malaria and health outcomes of children using a cluster-randomised design in Tororo, Uganda.
|
Implement Sci
|
2013
|
0.95
|
|
103
|
Profile of T cell immune responses in HIV-infected children from Uganda.
|
J Infect Dis
|
2007
|
0.95
|
|
104
|
Efficacy and safety of three regimens for the prevention of malaria in young HIV-exposed Ugandan children: a randomized controlled trial.
|
AIDS
|
2014
|
0.95
|
|
105
|
Comparing changes in haematologic parameters occurring in patients included in randomized controlled trials of artesunate-amodiaquine vs single and combination treatments of uncomplicated falciparum in sub-Saharan Africa.
|
Malar J
|
2012
|
0.93
|
|
106
|
Health facility-based malaria surveillance: the effects of age, area of residence and diagnostics on test positivity rates.
|
Malar J
|
2012
|
0.93
|
|
107
|
Breastfeeding and the risk of malaria in children born to HIV-infected and uninfected mothers in rural Uganda.
|
J Acquir Immune Defic Syndr
|
2010
|
0.92
|
|
108
|
Antimalarial therapies in children from Papua New Guinea.
|
N Engl J Med
|
2009
|
0.92
|
|
109
|
Virologic and immunologic outcomes of HIV-infected Ugandan children randomized to lopinavir/ritonavir or nonnucleoside reverse transcriptase inhibitor therapy.
|
J Acquir Immune Defic Syndr
|
2014
|
0.92
|
|
110
|
Prevalence of asymptomatic parasitemia and gametocytemia among HIV-infected Ugandan children randomized to receive different antiretroviral therapies.
|
Am J Trop Med Hyg
|
2013
|
0.91
|
|
111
|
Plasmodium falciparum dihydrofolate reductase and dihyropteroate synthase mutations and the use of trimethoprim-sulfamethoxazole prophylaxis among persons infected with human immunodeficiency virus.
|
Am J Trop Med Hyg
|
2010
|
0.91
|
|
112
|
Different methodological approaches to the assessment of in vivo efficacy of three artemisinin-based combination antimalarial treatments for the treatment of uncomplicated falciparum malaria in African children.
|
Malar J
|
2008
|
0.91
|
|
113
|
Estimation of malaria haplotype and genotype frequencies: a statistical approach to overcome the challenge associated with multiclonal infections.
|
Malar J
|
2014
|
0.89
|
|
114
|
Novel application of Locked Nucleic Acid chemistry for a Taqman assay for measuring diverse human immunodeficiency virus type 1 subtypes.
|
J Virol Methods
|
2010
|
0.89
|
|
115
|
Increased risk of early vomiting among infants and young children treated with dihydroartemisinin-piperaquine compared with artemether-lumefantrine for uncomplicated malaria.
|
Am J Trop Med Hyg
|
2010
|
0.88
|
|
116
|
Short-term risk of HIV disease progression and death in Ugandan children not eligible for antiretroviral therapy.
|
J Acquir Immune Defic Syndr
|
2010
|
0.86
|
|
117
|
HIV RNA suppression among HIV-infected Ugandan children with measles.
|
J Acquir Immune Defic Syndr
|
2008
|
0.85
|
|
118
|
Long-lasting insecticide-treated bed net ownership and use among children under five years of age following a targeted distribution in central Uganda.
|
Malar J
|
2014
|
0.85
|
|
119
|
The Distribution and Immune Profile of T Cell Subsets in HIV-Infected Children from Uganda.
|
AIDS Res Hum Retroviruses
|
2009
|
0.85
|
|
120
|
The effects of ACT treatment and TS prophylaxis on Plasmodium falciparum gametocytemia in a cohort of young Ugandan children.
|
Am J Trop Med Hyg
|
2013
|
0.84
|
|
121
|
The effect of HIV on malaria in the context of the current standard of care for HIV-infected populations in Africa.
|
Future Virol
|
2012
|
0.84
|
|
122
|
The effect of varying analytical methods on estimates of anti-malarial clinical efficacy.
|
Malar J
|
2009
|
0.84
|
|
123
|
An artesunate-containing antimalarial treatment regimen did not suppress cytomegalovirus viremia.
|
J Clin Virol
|
2013
|
0.83
|
|
124
|
Interaction of malaria and HIV in Africa.
|
BMJ
|
2009
|
0.83
|
|
125
|
Determination of the antimalarial drug piperaquine in small volume pediatric plasma samples by LC-MS/MS.
|
Bioanalysis
|
2014
|
0.82
|
|
126
|
Household food insecurity, maternal nutritional status, and infant feeding practices among HIV-infected Ugandan women receiving combination antiretroviral therapy.
|
Matern Child Health J
|
2014
|
0.81
|
|
127
|
The effect of malnutrition on the pharmacokinetics and virologic outcomes of lopinavir, efavirenz and nevirapine in food insecure HIV-infected children in Tororo, Uganda.
|
Pediatr Infect Dis J
|
2015
|
0.81
|
|
128
|
Short report: Dynamics of Plasmodium falciparum malaria after sub-optimal therapy in Uganda.
|
Am J Trop Med Hyg
|
2006
|
0.81
|
|
129
|
Virologic suppression in nevirapine-exposed HIV-infected infants initiating antiretroviral therapy in rural Uganda.
|
J Trop Pediatr
|
2011
|
0.81
|
|
130
|
Associations between antibodies to a panel of Plasmodium falciparum specific antigens and response to sub-optimal antimalarial therapy in Kampala, Uganda.
|
PLoS One
|
2012
|
0.80
|
|
131
|
Pattern of malaria-specific T-cell responses in a cohort of Ugandan children.
|
J Trop Pediatr
|
2007
|
0.80
|
|
132
|
HIV-1 infection in patients referred for malaria blood smears at government health clinics in Uganda.
|
J Acquir Immune Defic Syndr
|
2007
|
0.78
|
|
133
|
Tuberculosis Infection in Early Childhood and the Association with HIV-exposure in HIV-uninfected Children in Rural Uganda.
|
Pediatr Infect Dis J
|
2016
|
0.77
|
|
134
|
CD4 T cell activation as a predictor for treatment failure in Ugandans with Plasmodium falciparum malaria.
|
Am J Trop Med Hyg
|
2006
|
0.75
|